ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT

被引：0
作者：
Martomo, Stella [1 ]
Wang, George [1 ]
Polonskaya, Zhanna [1 ]
Luna, Xenia [1 ]
Lu, Dan [1 ]
Patel, Jeegar [1 ]
机构：
[1] Kadmon Corp, New York, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
652
引用
收藏
页码：A681 / A681
页数：1
相关论文
共 50 条
  • [21] Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
    Guo, Jingya
    Liang, Yong
    Xue, Diyuan
    Shen, Jiao
    Cai, Yueqi
    Zhu, Jiankun
    Fu, Yang-Xin
    Peng, Hua
    CELL RESEARCH, 2021, 31 (11) : 1190 - 1198
  • [22] Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
    Jingya Guo
    Yong Liang
    Diyuan Xue
    Jiao Shen
    Yueqi Cai
    Jiankun Zhu
    Yang-Xin Fu
    Hua Peng
    Cell Research, 2021, 31 : 1190 - 1198
  • [23] Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes
    Reyes, Anjelica F.
    Goldusky, Josef
    Bhimalli, Pavan
    Marzo, Amanda L.
    Schneider, Jeffrey R.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 505
  • [24] MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
    Yi, Ruibin
    Hong, Shuo
    Zhang, Yueming
    Lin, Anqi
    Ying, Haoxuan
    Zou, Weidong
    Wang, Qiongyao
    Wei, Ting
    Cheng, Quan
    Zhu, Weiliang
    Luo, Peng
    Zhang, Jian
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [25] A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity
    Shi, Wenqiang
    Lv, Liangyin
    Liu, Nan
    Wang, Hui
    Wang, Yang
    Zhu, Wen
    Liu, Zexin
    Zhu, Jianwei
    Lu, Huili
    MOLECULAR THERAPY, 2023, 31 (01) : 66 - 77
  • [26] Acidic tumor microenvironment-activated MRI nanoprobes for modulation and visualization of anti-PD-L1 immunotherapy
    Fan, Kai
    Yang, Xue
    Tian, Fang-zheng
    Li, Si-yu
    Zhang, Jian-qiong
    Xie, Jin-bing
    Ju, Sheng-hong
    NANO TODAY, 2024, 54
  • [27] Remodeling of the Tumor Microenvironment by a Chemokine/Anti-PD-L1 Nanobody Fusion Protein
    Fang, Tao
    Li, Ran
    Li, Zeyang
    Cho, Julia
    Guzman, Jonathan S.
    Kamm, Roger D.
    Ploegh, Hidde L.
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2838 - 2844
  • [28] Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
    Knudson, Karin M.
    Hicks, Kristin C.
    Ozawa, Yohei
    Schlom, Jeffrey
    Gameiro, Sofia R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [29] Preparation and anti-tumor ability evaluation of anti-PD-L1 conjugated curcumin in colon cancer
    Ding, Jie
    Liu, Zhenhua
    Liu, Sheng
    Xie, Xueqing
    Yin, Qingling
    Lu, Wei
    Wang, Wanchuan
    Zhang, Yi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [30] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
12345